Structure Therapeutics, Inc. (GPCR)
Structure Therapeutics Market Cap : 1.239B for Nov. 18, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 18, 2026 | 1.239B |
| November 17, 2026 | 1.297B |
| November 16, 2026 | 1.325B |
| November 13, 2026 | 1.427B |
| November 12, 2026 | 1.416B |
| November 11, 2026 | 1.495B |
| November 10, 2026 | 1.551B |
| November 09, 2026 | 1.528B |
| November 06, 2026 | 1.452B |
| November 05, 2026 | 1.362B |
| November 04, 2026 | 1.450B |
| November 03, 2026 | 1.449B |
| November 02, 2026 | 1.458B |
| October 30, 2026 | 1.558B |
| October 29, 2026 | 1.563B |
| October 28, 2026 | 1.530B |
| October 27, 2026 | 1.535B |
| October 26, 2026 | 1.503B |
| October 23, 2026 | 1.509B |
| October 22, 2026 | 1.562B |
| October 21, 2026 | 1.568B |
| October 20, 2026 | 1.629B |
| October 19, 2026 | 1.568B |
| October 16, 2026 | 1.501B |
| October 15, 2026 | 1.580B |
| Date | Value |
|---|---|
| October 14, 2026 | 1.558B |
| October 13, 2026 | 1.589B |
| October 12, 2026 | 1.703B |
| October 09, 2026 | 1.819B |
| October 08, 2026 | 1.828B |
| October 07, 2026 | 1.900B |
| October 06, 2026 | 1.956B |
| October 05, 2026 | 1.965B |
| October 02, 2026 | 1.971B |
| October 01, 2026 | 2.064B |
| September 30, 2026 | 2.227B |
| September 29, 2026 | 2.328B |
| September 28, 2026 | 2.497B |
| September 25, 2026 | 2.559B |
| September 24, 2026 | 2.565B |
| September 23, 2026 | 2.560B |
| September 22, 2026 | 2.629B |
| September 21, 2026 | 2.622B |
| September 18, 2026 | 2.493B |
| September 17, 2026 | 2.500B |
| September 16, 2026 | 2.528B |
| September 15, 2026 | 2.774B |
| September 14, 2026 | 2.738B |
| September 11, 2026 | 2.753B |
| September 10, 2026 | 2.817B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Eli Lilly & Co. | 1.301T |
| Novo Nordisk A/S | 131.93B |
| Merck & Co., Inc. | 339.87B |
| Prestige Consumer Healthcare, Inc. | 2.399B |
| Pfizer Inc. | 159.94B |
Market Cap Related Metrics
| PEG Ratio | -0.5449 |
| Price to Book Value | 1.014 |
| Price | 17.36 |
| Earnings Yield | -22.74% |
| PEGY Ratio | -0.5449 |